Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» opioid-induced constipation
opioid-induced constipation
Two years following US approval, Japan's Shionogi wins EU green light for opioid constipation drug
Endpoints
Fri, 02/22/19 - 10:17 am
Shionogi
Europe
opioid-induced constipation
Symproic
Rizmoic
When is bad press not so bad? When it's building a market, AstraZeneca says of its Super Bowl experiment
Fierce Pharma
Tue, 04/11/17 - 10:03 am
AstraZeneca
opioid-induced constipation
opioids
Valeant And Progenics Announce The U.S. Commercial Launch Of FDA-Approved Relistor® Tablets
Yahoo
Tue, 09/6/16 - 11:14 pm
Valeant Pharmaceuticals
Progenics
Relistor
opioid-induced constipation
How Will AstraZeneca (AZN) Stock React to FDA's Movantik Approval?
TheStreet.com
Tue, 09/16/14 - 01:41 pm
AstraZeneca
Movantik
FDA
opioid-induced constipation
Nektar
FDA approves AstraZeneca, Nektar constipation drug
Yahoo/Reuters
Tue, 09/16/14 - 11:55 am
FDA
AstraZeneca
Nektar
Movantik
opioid-induced constipation
AstraZeneca's Naloxegol Data Published
Yahoo/Zacks
Sat, 06/21/14 - 11:33 am
AstraZeneca
Naloxegol
opioid-induced constipation
FDA panel advises against large opioid-constipation drug safety trials
Yahoo/Reuters
Thu, 06/12/14 - 02:22 pm
FDA
advisory panels
opioid-induced constipation
U.S. FDA advisors set to review opioid constipation drugs
Yahoo/Reuters
Mon, 06/9/14 - 11:04 am
FDA
opioid-induced constipation
Salix
Relistor
Cubist Pharmaceuticals
Entereg
AstraZeneca
Nektar
Naloxegol
Nektar Rises on FDA Notification
Yahoo/Zacks.com
Thu, 03/20/14 - 09:07 am
FDA
Nektar
AstraZeneca
Naloxegol
opioid-induced constipation
Sucampo Receives $10 Million Milestone Payment from Takeda on First Sale of AMITIZA® (lubiprostone) for OIC in the US
Yahoo
Thu, 06/27/13 - 10:34 am
Sucampo
Takeda
Amitiza
opioid-induced constipation
AstraZeneca says Phase III studies of Naloxegol met primary, secondary endpoints
The Fly on the Wall
Tue, 05/21/13 - 10:12 am
AstraZeneca
Naloxegol
opioid-induced constipation
Sucampo Wins Approval for Expanded Use of Amitiza in U.S.
Bloomberg
Tue, 04/23/13 - 10:49 am
Sucampo
Amitiza
opioid-induced constipation
Strength In Sucampo Heading Into FDA Decision And Analyst Activity
Seeking Alpha
Fri, 04/5/13 - 10:50 am
Sucampo
FDA
Rescula
Amitiza
opioid-induced constipation